CYP26A1 as a New Prognostic Biomarker With Immune Infiltration in Thyroid Cancer

Tingting Cui, Ying Zhang, Weida Liu, Danzhen Zhang, Haiying Gong

PDF(7493 KB)
For Authors|For Editors|For Reviewers
PDF(7493 KB)
Discovery Medicine ›› 2026, Vol. 38 ›› Issue (207) : 1131-1147. DOI: 10.24976/Discov.Med.202638207.91
Article

CYP26A1 as a New Prognostic Biomarker With Immune Infiltration in Thyroid Cancer

    {{javascript:window.custom_author_en_index=0;}}
  • {{article.zuoZhe_EN}}
Author information +
History +

Highlight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations
{{article.zuoZheEn_L}}. {{article.title_en}}. {{journal.qiKanMingCheng_EN}}. 2026, 38(207): 1131-1147 https://doi.org/10.24976/Discov.Med.202638207.91

References

Publishing order | Descend order by publishing year | Descend order by cited within

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}
{{article.copyrightLicense_en}}
PDF(7493 KB)

Accesses

Citation

Detail
Sections
Recommended
Follow Us on
Copyright © 2026.
By using this website, you agree to our Terms & Conditions and Privacy Policy.  
  • Disclaimer
    The statements, opinions and data contained in Discovery Medicine are solely those of the individual authors and contributors and not of the journal and the editor(s). Discovery Medicine stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

    • /

    〈 〉